About Soleus Capital
Soleus Capital is a private equity firm founded in 2018. It is primarily based in Greenwich, United States. In the last 12 months, it has participated in 3 funding rounds.
Overall Soleus Capital portfolio has seen 1 unicorn, 16 IPOs and 11 acquisitions including key companies like OrganOx, Septerna and Beta Bionics. A lot of funds co-invest with Soleus Capital, with names like RA Capital Management sharing a substantial percentage of its portfolio.
Soleus Capital has a team of 16 people, including 4 partners.
Key Metrics
Soleus Capital's Portfolio
They have invested in a total of 45 companies. Their most recent investment was in Parabilis Medicines (Series F round) on Jan 08, 2026. Here is the most recent investment by Soleus Capital:Date | Company | Round | Amount | Co-Investors |
|---|---|---|---|---|
Jan 08, 2026 | Series F | 7723 | ||
Sep 30, 2025 | Series D | 2678 | ||
May 27, 2025 | Series C | 6604 | ||
Mar 28, 2025 | Series E | 1959 |
Here is the portfolio snapshot of Soleus Capital:
Investments by Year
The maximum number of investments were made in 2021
Team profile of Soleus Capital
Soleus Capital has a team of 16 members including 4 Partners located in United States. Soleus Capital's team does not sit on the board of any company as of now.Here is a list of top team members in Soleus Capital:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Greenwich | - | ||
Partner | Greenwich | - | ||
Partner | Greenwich | - | ||
Partner | New York City | - | ||
Associate | New York City | - | ||
Associate | New York | - | ||
Analyst | New York City | - | ||
Analyst | New York City | - | ||
Analyst | New York | - | ||
Analyst | New York City | - | - | |
Analyst | Los Angeles | - |
Co-investors of Soleus Capital
Over the past 8 years, 158 investors have co-invested in Soleus Capital's portfolio companies.
- Top Co-investors of Soleus Capital: 158 investors entered a company along with Soleus Capital. These include investors like RA Capital Management (14 companies).
Soleus Capital News
•
Adlai Nortye Announces $150.0 Million Private PlacementGlobeNewswire•Apr 16, 2026•Perceptive Advisors, Soleus Capital, Adlai Nortye
•
Heidelberg Pharma Receives $20M Funding via Amended Royalty AgreementWebDisclosure•Mar 09, 2026•Heidelberg Pharma, Soleus Capital, Telix Pharma, HCRx and 1 other
•
Parabilis gets $305M to conquer 'undruggable' proteins after early successEndpoints•Jan 08, 2026•Parabilis Medicines, Johnson & Johnson, Frazier Life Sciences, Rock Springs Capital and 19 others
•
Quoin Pharmaceuticals Announces Private Placement Financing of Up to $104.5 MillionBenzinga•Oct 10, 2025•Nantahala Capital Management, Stonepine, Soleus Capital, Quoin Pharmaceuticals and 4 others
•
•
Pillar Biosciences Raises $34.5M in FundingFinSMEs•May 27, 2025•Pillar Biosciences, Illumina, Soleus Capital
•
•
Soleus Capital Urges Theratechnologies Board to Accept Acquisition OfferFinancial Post•Apr 12, 2025•Soleus Capital, Theratechnologies
•
Neurona raises $102m to advance cell therapy for drug-resistant epilepsyPharmaceutical Technology•Apr 03, 2025•Neurona Therapeutics, Fidelity Investments, The Column Group, Soleus Capital and 1 other
•
PE-backed medical technology company secures $142m to accelerate growth opportunities in organ technology marketInsider Media•Feb 27, 2025•OrganOx, Health Quest Capital, BGF, Lauxera Capital Partners and 5 others
